Home › NDC Lookup › RxCUI directory › RxCUI 2121072

Bismuth subsalicylate 262 MG Oral Capsule — RxCUI 2121072

RxNorm drug concept · Semantic clinical drug
RxCUI 2121072 Semantic clinical drug · SCD ● Current RxNorm concept 10 FDA products 12 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2121072
Official nameBismuth subsalicylate 262 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped10
Package NDCs mapped12
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Bismuth Subsalicylate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's used to calm a range of stomach and digestive problems — things like diarrhea, traveler's diarrhea, heartburn, indigestion, nausea, gas, belching, and that uncomfortable over-...
  • What is bismuth subsalicylate actually used for?
  • Don't panic — that's actually a very common and completely harmless side effect of bismuth subsalicylate. The medicine can temporarily turn your stool and even your tongue a dark o...
  • Why did my stool turn black after taking this? Should I be worried?
📖 Read our full Bismuth Subsalicylate guide →

🕸️ Concept Web — How Bismuth subsalicylate 262 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Bismuth subsalicylate 262 MG Oral Capsule RxCUI 2121072

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Bismuth subsalicylate 19478
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Pepto-bismol 54536
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Bismuth subsalicylate Oral Capsule 2121071
    • Bismuth subsalicylate Oral Product 1161839
    • Bismuth subsalicylate Pill 1161840
    • Bismuth subsalicylate Oral Capsule [Pepto-bismol] 2121073
    • Pepto-bismol Oral Product 1185222
    • Pepto-bismol Pill 1185223
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Bismuth subsalicylate 262 MG SCDC · 315491
  • Bismuth subsalicylate Oral Capsule SCDF · 2121071
  • Bismuth subsalicylate Oral Product SCDG · 1161839
  • Bismuth subsalicylate Pill SCDG · 1161840

Brand-Name Concepts

  • Bismuth subsalicylate 262 MG Oral Capsule [Pepto-bismol] SBD · 2121074
  • Bismuth subsalicylate 262 MG [Pepto-bismol] SBDC · 571611
  • Bismuth subsalicylate Oral Capsule [Pepto-bismol] SBDF · 2121073
  • Pepto-bismol Oral Product SBDG · 1185222
  • Pepto-bismol Pill SBDG · 1185223
  • Pepto-bismol BN · 54536

📦 FDA Products & Package NDCs

10 products · 12 package NDCs
12 package NDCs map to RxCUI 2121072 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
35916-0234-01 1 BLISTER PACK in 1 CARTON (35916-0234-1) / 10 CAPSULE, LIQ... Bismuth subsalicylate Softgel Healthcare Pvt Ltd 2024-05-27
37000-0535-12 1 BLISTER PACK in 1 CARTON (37000-535-12) / 12 CAPSULE, LIQ... Pepto Bismol Liquicaps The Procter & Gamble Manufacturing Company 2019-03-01
37000-0535-24 2 BLISTER PACK in 1 CARTON (37000-535-24) / 12 CAPSULE, LIQ... Pepto Bismol Liquicaps The Procter & Gamble Manufacturing Company 2019-03-01
37000-0535-48 4 BLISTER PACK in 1 CARTON (37000-535-48) / 12 CAPSULE, LIQ... Pepto Bismol Liquicaps The Procter & Gamble Manufacturing Company 2019-03-01
51316-0829-22 1 BLISTER PACK in 1 CARTON (51316-829-22) / 12 CAPSULE, LIQ... CVS Health Stomach Relief SOFTGEL CVS Pharmacy, Inc. 2025-01-24
70692-0829-84 48 CAPSULE, LIQUID FILLED in 1 BOTTLE (70692-829-84) RIGHT REMEDIES Stomach Relief BISMUTH SUBSALICYLATE 262 mg softgel Strive Pharmaceuticals Inc. 2025-09-23
72090-0053-01 48 CAPSULE, LIQUID FILLED in 1 BOTTLE (72090-053-01) Upset Stomach Relief-Bismuth Subsalicylate 262 mg Pioneer Life Sciences, LLC 2025-06-27
82706-0028-01 1 BOTTLE in 1 CARTON (82706-028-01) / 48 CAPSULE, LIQUID FI... FEVIA Diarrhea Control VIVUNT PHARMA LLC 2026-02-18
82706-0028-02 1 BOTTLE in 1 CARTON (82706-028-02) / 24 CAPSULE, LIQUID FI... FEVIA Diarrhea Control VIVUNT PHARMA LLC 2026-02-18
83059-0026-08 1 BOTTLE in 1 CARTON (83059-0026-8) / 8 CAPSULE, LIQUID FIL... Stomach Relief Shield Pharmaceuticals Corp 2024-04-07
83059-0111-08 1 BLISTER PACK in 1 CARTON (83059-0111-8) / 8 CAPSULE, LIQU... Stomach Relief Shield Pharmaceuticals Corp 2025-11-11
84324-0028-01 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (84324-028-01) Upset Stomach Relief-Bismuth Subsalicylate 262 mg NUVICARE LLC 2025-06-25
Observed labelers: The Procter & Gamble Manufacturing Company (3) · Shield Pharmaceuticals Corp (2) · VIVUNT PHARMA LLC (2) · CVS Pharmacy, Inc. (1) · NUVICARE LLC (1) · Pioneer Life Sciences, LLC (1) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.